vs
Side-by-side financial comparison of Stereotaxis, Inc. (STXS) and TECOGEN INC. (TGEN). Click either name above to swap in a different company.
Stereotaxis, Inc. is the larger business by last-quarter revenue ($8.6M vs $5.3M, roughly 1.6× TECOGEN INC.). Stereotaxis, Inc. runs the higher net margin — -64.0% vs -75.1%, a 11.1% gap on every dollar of revenue. On growth, Stereotaxis, Inc. posted the faster year-over-year revenue change (36.3% vs -12.5%). Over the past eight quarters, Stereotaxis, Inc.'s revenue compounded faster (12.1% CAGR vs -7.3%).
Stereotaxis Inc. is an American publicly traded medical technology company based in St. Louis, Missouri, that makes robotic systems used by physicians to perform minimally-invasive endovascular procedures, including electrophysiology studies and cardiac catheter ablation procedures.
STXS vs TGEN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.6M | $5.3M |
| Net Profit | $-5.5M | $-4.0M |
| Gross Margin | 50.1% | 36.8% |
| Operating Margin | -65.4% | -77.8% |
| Net Margin | -64.0% | -75.1% |
| Revenue YoY | 36.3% | -12.5% |
| Net Profit YoY | 26.4% | -236.7% |
| EPS (diluted) | $-0.06 | $-0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $8.6M | $5.3M | ||
| Q3 25 | $7.5M | $7.2M | ||
| Q2 25 | $8.8M | $7.3M | ||
| Q1 25 | $7.5M | $7.3M | ||
| Q4 24 | $6.3M | $6.1M | ||
| Q3 24 | $9.2M | $5.6M | ||
| Q2 24 | $4.5M | $4.7M | ||
| Q1 24 | $6.9M | $6.2M |
| Q4 25 | $-5.5M | $-4.0M | ||
| Q3 25 | $-6.5M | $-2.1M | ||
| Q2 25 | $-3.8M | $-1.5M | ||
| Q1 25 | $-5.8M | $-659.9K | ||
| Q4 24 | $-7.5M | $-1.2M | ||
| Q3 24 | $-6.2M | $-930.4K | ||
| Q2 24 | $-5.8M | $-1.5M | ||
| Q1 24 | $-4.5M | $-1.1M |
| Q4 25 | 50.1% | 36.8% | ||
| Q3 25 | 54.9% | 30.4% | ||
| Q2 25 | 52.0% | 33.8% | ||
| Q1 25 | 54.4% | 44.3% | ||
| Q4 24 | 50.7% | 45.0% | ||
| Q3 24 | 44.6% | 44.1% | ||
| Q2 24 | 73.6% | 44.0% | ||
| Q1 24 | 57.6% | 41.6% |
| Q4 25 | -65.4% | -77.8% | ||
| Q3 25 | -87.8% | -29.2% | ||
| Q2 25 | -45.2% | -19.4% | ||
| Q1 25 | -79.3% | -8.2% | ||
| Q4 24 | -120.3% | -18.7% | ||
| Q3 24 | -69.0% | -15.5% | ||
| Q2 24 | -133.7% | -31.2% | ||
| Q1 24 | -69.0% | -17.0% |
| Q4 25 | -64.0% | -75.1% | ||
| Q3 25 | -86.6% | -29.7% | ||
| Q2 25 | -43.5% | -20.1% | ||
| Q1 25 | -77.9% | -9.1% | ||
| Q4 24 | -118.5% | -19.5% | ||
| Q3 24 | -67.3% | -16.5% | ||
| Q2 24 | -129.6% | -32.5% | ||
| Q1 24 | -65.5% | -17.9% |
| Q4 25 | $-0.06 | $-0.14 | ||
| Q3 25 | $-0.07 | $-0.07 | ||
| Q2 25 | $-0.05 | $-0.06 | ||
| Q1 25 | $-0.07 | $-0.03 | ||
| Q4 24 | $-0.09 | $-0.05 | ||
| Q3 24 | $-0.08 | $-0.04 | ||
| Q2 24 | $-0.07 | $-0.06 | ||
| Q1 24 | $-0.06 | $-0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.4M | $12.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $13.5M | $21.6M |
| Total Assets | $52.3M | $37.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.4M | $12.4M | ||
| Q3 25 | $10.5M | $15.3M | ||
| Q2 25 | $7.0M | $1.6M | ||
| Q1 25 | $10.6M | $4.1M | ||
| Q4 24 | $12.2M | $5.4M | ||
| Q3 24 | $10.7M | $1.3M | ||
| Q2 24 | $14.7M | $841.9K | ||
| Q1 24 | $17.6M | $1.5M |
| Q4 25 | $13.5M | $21.6M | ||
| Q3 25 | $6.3M | $25.5M | ||
| Q2 25 | $1.5M | $9.1M | ||
| Q1 25 | $2.9M | $9.6M | ||
| Q4 24 | $6.1M | $10.2M | ||
| Q3 24 | $10.8M | $11.3M | ||
| Q2 24 | $11.4M | $12.2M | ||
| Q1 24 | $14.6M | $13.7M |
| Q4 25 | $52.3M | $37.0M | ||
| Q3 25 | $45.6M | $41.5M | ||
| Q2 25 | $41.2M | $28.4M | ||
| Q1 25 | $45.7M | $29.7M | ||
| Q4 24 | $46.7M | $31.1M | ||
| Q3 24 | $50.9M | $27.5M | ||
| Q2 24 | $36.0M | $27.2M | ||
| Q1 24 | $39.5M | $28.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.0M | $-2.6M |
| Free Cash FlowOCF − Capex | — | $-2.6M |
| FCF MarginFCF / Revenue | — | -49.3% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-10.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-4.0M | $-2.6M | ||
| Q3 25 | $-4.2M | $-3.6M | ||
| Q2 25 | $-3.7M | $-2.6M | ||
| Q1 25 | $-1.8M | $-1.2M | ||
| Q4 24 | $1.3M | $4.2M | ||
| Q3 24 | $-4.3M | $-207.3K | ||
| Q2 24 | $-3.1M | $-157.9K | ||
| Q1 24 | $-2.3M | $248.2K |
| Q4 25 | — | $-2.6M | ||
| Q3 25 | — | $-3.6M | ||
| Q2 25 | — | $-2.7M | ||
| Q1 25 | — | $-1.3M | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | $-4.3M | $-489.6K | ||
| Q2 24 | — | $-609.6K | ||
| Q1 24 | — | $143.3K |
| Q4 25 | — | -49.3% | ||
| Q3 25 | — | -50.6% | ||
| Q2 25 | — | -37.7% | ||
| Q1 25 | — | -17.9% | ||
| Q4 24 | — | 66.6% | ||
| Q3 24 | -47.2% | -8.7% | ||
| Q2 24 | — | -12.9% | ||
| Q1 24 | — | 2.3% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | 0.0% | 1.0% | ||
| Q2 25 | — | 2.0% | ||
| Q1 25 | — | 1.8% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | 0.1% | 5.0% | ||
| Q2 24 | — | 9.6% | ||
| Q1 24 | — | 1.7% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
STXS
| Disposables Service And Accessories | $5.3M | 61% |
| Systems | $3.4M | 39% |
TGEN
| Installation Services | $4.5M | 84% |
| Products Segment | $460.5K | 9% |
| Other | $394.7K | 7% |
